JPMA Charter of Corporate Behavior Revised October 18, 2018, implemented April 1, 2019
The mission of pharmaceutical companies is to contribute to the improvement of the welfare and healthcare of people around the world through the continuous development and stable supply of superior pharmaceutical products, thereby contributing to the realization of healthy and high quality of life. To achieve this mission, the pharmaceutical industry is required to pursue the ever-advancing life sciences with sincerity and relentless pursuit of excellence, and to conduct its business with the highest ethical standards and transparency.
In 1997, JPMA established the "JPMA Charter of Corporate Behavior" (hereinafter referred to as the "Charter") to help member companies fulfill their mission as pharmaceutical companies. In addition to fulfilling the mission of pharmaceutical companies, we have recently revised this Charter with a focus on contributing to the sustainable development of society through business activities that take ESG (Environmental, Social and Governance) into consideration, as well as contributing to the realization of a sustainable society.